By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

iBeat 

70 South Park Street

San Francisco  California  94107  U.S.A.
Phone: 415-496-9682 Fax: n/a


SEARCH JOBS

Located in the heart of San Francisco, iBeat is a technology company empowering people with the freedom to be fearless, take risks, explore, and live longer lives. From a life-saving health records platform to a life-saving Wearable-as-a-Service™, the iBeat team is comprised of several former Practice Fusion veterans dedicated to improving health outcomes and helping pave the future of care delivery.

The company is currently building a breakthrough wearable that perpetually monitors and analyzes users’ 24-7 heart activity. In the case of a life-threatening emergency, iBeat will instantly alert the user, their loved ones, and emergency responders in real-time, helping ensure immediate care delivery and potentially saving the user’s life.

YEAR FOUNDED:

2016

LEADERSHIP:

Founder & CEO: Ryan Howard

Co-Founder & Lead Front-End Architect: Larry Stone

Co-Founder & Director of Product: Brian Boarini

CAREER:

Please click here for iBeat's job opportunities.


Key Statistics


Email: support@ibeat.com
Ownership: Private

Web Site: iBeat
Employees:
Symbol: 
 



Industry
Diagnostics






Company News
GeoVax, Inc. And ViaMune To Collaborate On Cancer Immunotherapy Program 11/8/2016 10:39:25 AM
GeoVax, Inc. Begins Oncology Immunotherapy Program 12/9/2015 11:38:56 AM
Farshad Guirakhoo, Ph.D., Joins GeoVax, Inc. As Senior Vice President, Research And Development 10/20/2015 1:07:34 PM
GeoVax, Inc. Reports 2015 Second Quarter Financial Results And Provides Corporate Update 8/4/2015 10:02:06 AM
GeoVax, Inc. Receives Grant From NIH For HIV Vaccine Program 7/2/2015 11:08:58 AM
GeoVax Labs Inc. (GOVX.OB) DNA/MVA Vaccine Elicits Sustained Antibody Responses to HIV 10/9/2013 10:31:13 AM
GeoVax Labs Inc. (GOVX.OB) Reports Financial Results for the Second Quarter and First Half 2013 and Provides Clinical Development Update 8/13/2013 9:18:22 AM
GeoVax Labs Inc. (GOVX.OB) Announces Enrollment Completion for Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine 1/10/2013 8:57:28 AM
GeoVax Labs Inc. (GOVX.OB) to Present at Fifth Annual LD Micro Conference 11/29/2012 9:09:28 AM
GeoVax Labs Inc. (GOVX.OB) Reports 2012 Second Quarter Financial Results 8/13/2012 8:57:24 AM
123
//-->